Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilect in Korean Parkinson's Patients with Motor Fluctuations
NCT01268891Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jan 2011
- Primary completion
- Jun 2012
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Lundbeck. Started Jan 2011; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01268891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268891.